Poseida Therapeutics, Inc.
PSTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $44 | $81 | $206 | $84 |
| Short-Term Investments | $168 | $201 | $0 | $225 |
| Receivables | $9 | $9 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $7 | $8 | $5 |
| Total Curr. Assets | $226 | $299 | $214 | $314 |
| Property Plant & Equip (Net) | $41 | $47 | $48 | $48 |
| Goodwill | $4 | $4 | $4 | $4 |
| Intangibles | $1 | $1 | $1 | $1 |
| Long-Term Investments | $0 | -$9 | -$9 | -$9 |
| Tax Assets | $0 | $9 | $9 | $9 |
| Other NC Assets | $1 | $1 | $2 | $4 |
| Total NC Assets | $47 | $53 | $55 | $57 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $274 | $352 | $269 | $371 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $9 | $1 |
| Short-Term Debt | $6 | $6 | $13 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $31 | $20 | $4 | $23 |
| Other Curr. Liab. | $31 | $26 | $17 | $20 |
| Total Curr. Liab. | $71 | $54 | $43 | $30 |
| LT Debt | $79 | $83 | $80 | $55 |
| Deferred Rev, NC | $17 | $21 | $9 | $24 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $6 | -$20 | $25 |
| Total NC Liab. | $99 | $110 | $70 | $79 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $27 | $31 | $32 | $30 |
| Total Liabilities | $170 | $164 | $113 | $110 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$594 | -$471 | -$407 | -$282 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $698 | $659 | $563 | $544 |
| Total Equity | $104 | $188 | $156 | $262 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $274 | $352 | $269 | $371 |
| Net Debt | $41 | $7 | -$113 | -$20 |